Nurix Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 07:00 ET
|
Nurix Therapeutics, Inc.
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat...